Reporter Jan 13 2023

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
January 9, 2023

Nashville Biosciences and Illumina announce sequencing agreement with Amgen

Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.

By VUMC News and Communications
1 2